Alnylam Reports Positive Initial Results from Ongoing Phase 1/2 Study of ALN-GO1, an Investigational RNAi Therapeutic for the Treatment of Primary Hyperoxaluria Type 1
Novacyt provides a business update
WiFi SPARK appoints Tracy Scriven as Director of Healthcare UK
Positive Results From the COPD Salford Lung Study Published in the NEJM and Presented at European Respiratory Congress
HealthTap Launches a New Company in Great Britain
These closed-end funds were unstoppable in early 2015; plus, did the first IPO of 2015 usher in a new era for CEF shareholders?
Dan Plettner invests and receives income for securities research, including “buy-side” research. Dan licenses his own real time trading data to Covestor Ltd. (“Covestor”), frequently including positions discussed in his Morningstar Contributions. Covestor is a Registered Investment Advisor that ...